Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
Ocular diseases cause visual impairment and blindness, imposing a devastating impact on quality of life and a substantial societal economic burden. Many such diseases lack universally effective pharmacotherapies. Therefore, understanding the mediators involved in their pathophysiology is necessary f...
Main Authors: | Bomina Park, Timothy W. Corson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00095/full |
Similar Items
-
Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
by: Bomina Park, et al.
Published: (2022-12-01) -
Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
by: Rebecca Charles, et al.
Published: (2022-06-01) -
The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023-02-01) -
Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases
by: Trupti Shetty, et al.
Published: (2020-07-01) -
Association between the soluble epoxide hydrolase gene and preeclampsia
by: Ismail Sari, et al.
Published: (2017-10-01)